XML 60 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements (Additional Information) (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2022
Nov. 30, 2022
Nov. 10, 2022
Jun. 02, 2022
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]                      
Principle amount of issued debt             $ 25,000        
Loss (gain) on derivative liability         $ 82 $ 2,700 5,335 $ (4,800) $ (8,310) $ 300 $ (800)
Liabilities, Fair Value Adjustment       $ 30,400              
Risk Adjusted Net Sales Forecast           6.10%   6.10%      
Debt Securities, Available-for-Sale, Weighted Average Yield           21.50%   21.50%      
Common stock upon conversation of cash             $ 3,000   $ 3,000    
Discount rate of FDA 10.00%       10.60%   10.60%   10.00%    
Development Milestone Payment $ 200           $ 200        
Derivative warrant liability private warrants $ 1,200           6,600        
Change in fair value of convertible debentures             (3,460)        
Convertible Debentures [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Change in fair value of convertible debentures             $ 3,700        
Private Placement [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Derivative warrant liability private warrants   $ 2,500 $ 2,500